Continuous treatment histories and dose responses in panels
LLM status Open unverified
C23 — Panel Data Models - Spatio-temporal Models Economics catalogue openaigpt 6 astra ultra 45% cataloguednot recordedOpenStatement
ECON-017 | R | Source-backed agenda; exact formalization is editorial
Definitions and formal target
Now treatment is a dose $D_{it}\in[0,1]$ and $Y_{it}(d_{1:t})$ is a path-indexed potential outcome. Let $Q$ be a specified distribution of baseline treatment paths. A bounded perturbation $h(d)=(h_s(d))_{s\leq t}$ satisfies $d+\eta h(d)\in[0,1]^t$ for sufficiently small $\eta$.
Define the pathwise dose-response derivative, when it exists, \[ \Psi_t(h)=\left.\frac{d}{d\eta}\mathbb E_{d\sim Q}\mathbb E[Y_{it}(d+\eta h(d))]\right|_{\eta=0}. \] Identify or bound $\Psi_t(h)$ with latent unit heterogeneity and endogenous dose choices; specify overlap and smoothness conditions needed for valid uncertainty statements.
Clarifications and required assumptions
Fix a baseline path law $Q$ and a measurable direction $h(d)\in\mathbb R^t$, both independently of the outcome sample. For a two-sided derivative, require $d+\eta h(d)\in[0,1]^t$ for $Q$-almost every $d$ and every $|\eta|<\eta_0$. At a boundary only a specified one-sided derivative may exist. Define the target directly as the derivative of an integral; interchanging differentiation and expectation additionally needs a dominating integrable derivative bound. Consistency and the no-interference convention are as in ECON-014.
Variants and changes of scope
Level response. Estimate $d\mapsto\mathbb E_mY_{it}(d)$, rather than assuming differentiability. Dose intervention. Specify one-date, persistent, or path-dependent shifts; the directions differ. Overlap. Require treatment densities bounded away from zero on the support queried, or report partial identification for unsupported paths. Latent heterogeneity. Add finite-rank or parametric restrictions explicitly. For continuously distributed doses, identification at an exact point usually also needs a regular version or smoothness, beyond ordinary binary overlap.
Audit conclusion and source relationship
Section 10.5 genuinely calls for continuous-treatment work. This particular path derivative is editorial. The revision clarifies the feasible-direction and differentiation assumptions and does not label all dose-response analysis an unsolved theorem.
References and exact source roles
[S1] Dmitry Arkhangelsky and Guido Imbens (2024). Causal Models for Longitudinal and Panel Data: A Survey. The Econometrics Journal 27(3), C1--C61, DOI: 10.1093/ectj/utae014. Checked author version: arXiv:2311.15458v3, 25 June 2024.
Verified locator / source role: Section 10.5 in the checked June 2024 author version. The journal landing page was verified for metadata; the readable author PDF was used for the agenda.
https://arxiv.org/pdf/2311.15458
Common conventions: Additional-source status and mathematical conventions
Of the 100 supplied ECON entries, 65 distinct problems appear here; 32 close matches refine earlier entries, and three duplicate questions map to existing entries. Appendix app:audited-crosswalk lists every destination. The attachment's P/R/S/U distinctions and source audits are retained. Its precise mathematical formalizations are editorial unless the individual audit says otherwise. Candidate subsidy targets ECON-004--006 retain their U flags; the resolved approval-core question ECON-007 updates OP-0202 above. The following supplied conventions govern both this part and the attributed ECON refinements elsewhere in the catalogue, subject to local restrictions.
Parameterized questions. A problem family lists inputs that must be fixed before an instance is evaluated: population, horizon, policies, information, data law, model class and welfare weights. These are required choices, not quantities the citations are assumed to specify. Undefined applications should not be treated as identified estimands.
Indices and integrability. Sets of agents, firms and regions are finite unless a population measure is explicitly used. $i,j$ index units, $r$ regions, $t$ dates and $h$ horizons. $\mathbb E$ and $\Pr$ refer to the declared population and law; $\mathbf1\{A\}$ is an indicator. Every displayed expectation and discounted sum needs existence in the stated domain. Infinite horizons use a discount in $(0,1)$ and a convergence condition; finite horizons may use discount one.
Optimization and existence. A displayed $\max$, $\min$, or $\arg\max$ is conditional on attainment. For finite feasible menus this is immediate; general spaces need continuity and compactness/coercivity or another existence argument. Without attainment, the target is the supremum/infimum and arbitrarily near-optimal feasible choices. $\inf\varnothing=+\infty$. Empty feasibility and an unidentified target are different issues.
Potential outcomes. $Y_i(z)$ is the outcome under a specified intervention, not the observed conditional mean among people choosing $z$. In binary comparisons $\Delta Y_i=Y_i(1)-Y_i(0)$. Specify assignment, treatment versions, compliance, information and observation horizon. Interference is allowed under a full policy vector; compressed exposure notation needs a justified mapping. No interference, consistency and overlap are substantive assumptions, not automatic consequences of notation.
Populations and observation. Fix baseline eligibility and population weights. Conditioning on post-policy employment, survival, relocation or program uptake can change the population being compared. Death is not ordinary loss to follow-up; outcomes truncated by death need a composite convention, joint survival target, or explicitly defined survivor stratum. Fertility-changing interventions need a population functional rather than an unexplained fixed descendant cohort. Measurement and missingness models must be supplied.
Identification. A structural model $m\in\mathcal M$ implies observable law $P_m$ and target $\theta(m)$. Identification means \[ P_{m_1}=P_{m_2}\ \Longrightarrow\ \theta(m_1)=\theta(m_2) \quad\text{for all }m_1,m_2\in\mathcal M . \] Without identification, the target is \[ \Theta(P;\mathcal M)=\{\theta(m):m\in\mathcal M,\ P_m=P\}. \] Writing $\theta(P)$ before establishing identification can hide incompatible latent models. Confidence sets additionally need a sampling law, confidence level, asymptotic sequence and uniformity class. Point identification, coverage and informative precision are separate properties.
Mediation. Total effects of randomized assignment are distinct from cross-world natural indirect effects. Belief/effort-channel effects require a meaningful mediator intervention and additional measurement, exclusion or mediation assumptions. Randomization of the initial policy alone does not supply those assumptions. Report bounds or interventional alternatives when the stronger target is unsupported.
Equilibrium. A counterfactual $W(z)$, $p(z)$, or $\mu_t^z$ requires individual optimization, feasibility, government/resource budgets, market clearing and state-transition laws. State equilibrium existence and selection, or report ranges over compatible equilibria. Initial-state integration includes subsequent endogenous transitions; current-state integration must use the policy-dependent distribution. Reduced-form invariance after policy is not assumed.
Welfare accounts. Scores, utility, health, dollars and ecological quantities require explicit conversion before addition. Fees, taxes, subsidies, wages and extortion payments are transfers between parties; distributional weights can make them welfare relevant, but their face value is not automatically a resource loss. State ownership, geographic boundaries, foreign-income weights and fiscal finance. Do not add profits to household welfare already including dividends, or count land capitalization and the underlying benefit twice. A benefit-cost expression must distinguish gross benefits from net welfare and subtract every real cost exactly once.
Derivatives and risk. Log derivatives require positive arguments; local responses require admissible perturbations and specified equilibrium branches. Differentiation under expectations needs regularity/domination, and boundaries may allow only one-sided derivatives. Risk uses a specified law; ambiguity uses a declared nonempty law set on a common history space. Adaptive policies must be nonanticipative. A robust criterion is an editorial choice unless attributed explicitly.
Scope overlaps. Allocation, collective choice, contracts, household bargaining and coordinated policy overlap economics with optimization and game theory. They are retained because they appeared in the original catalogue; no claim of a strictly game-theory-free selection is made.
Statement licence: CC-BY-4.0 · Source file
Contributions 1
GPT 6 Astra Ultra attempt on Econ-230
Continuous treatment histories and dose responses in panels: overlap is insufficient, but integrated derivatives can be regular
Scope
For a terminal potential outcome under a continuous treatment history $d\in[0,1]^t$, let $\mu(d)=E[Y_t(d)]$. The marginal path perturbation target is \[ \Psi_t(h)=\left.\frac{d}{d\eta}E_{D\sim Q}\mu(D+\eta h(D))\right|_{\eta=0}. \] Section 10.5 of [panel] identifies continuous treatments as a frontier in panel causal models. The first result shows that overlap and smooth dose response do not identify this target in a latent-confounding model. The second provides an identification and inference route under exogeneity, without pretending that exogeneity follows from observing a long panel.Under intervention on $d$, however, $U$ keeps its marginal distribution, and $\mu_\theta(d)=1/2-\theta av(d)$. This is linear and smooth. Differentiating along the compactly supported path yields $\Psi_t^{\theta}(h)=-2a\theta E_Qh_t(D)$, which varies with $\theta$. All structural outcome randomness is represented by the independent $R$, while confounding arises through the common latent $U$. ∎
Remaining gap
The counterexample leaves open which panel restrictions, instruments, or sequential assumptions identify effects under endogeneity. The positive result uses full exogeneity and either supplied design density or an independently trained density with a controlled product remainder. It does not solve uniform inference with unknown high-dimensional treatment assignment or establish the original problem's sharp dependence on history length and smoothness.Completion Estimate
45%This is a post hoc, heuristic estimate for the full catalogue target. The attempt proves smooth nonidentification under endogenous dose histories and derives regular integrated-derivative inference under exogeneity, including an unknown-density remainder. Identifying restrictions for endogenous panels and uniform inference with unknown high-dimensional assignment, history-length dependence and smoothness remain unestablished.
References
- [panel] D. Arkhangelsky and G. Imbens. Causal models for longitudinal and panel data: A survey. The Econometrics Journal 27 (2024), C1--C61. Author version, Section 10.5: https://arxiv.org/pdf/2311.15458.